PUBLISHER: TechSci Research | PRODUCT CODE: 1131715
PUBLISHER: TechSci Research | PRODUCT CODE: 1131715
Global Photoimmunotherapy Market By Therapeutic Area, By End User, and By Region, Competition Forecast and Opportunities, 2027
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global photoimmunotherapy market is anticipated to witness robust CAGR in the forecast period, 2023-2027. Factors such as the increasing prevalence of cancer worldwide, growing healthcare expenditure, and ongoing research and development activities to find novel cancer treatment therapies primarily drive the demand for the global photoimmunotherapy market. The rise in the investments by the leading authorities to develop the healthcare infrastructure and hire skilled healthcare professionals and favorable government reimbursement policies are the other prominent factors that can accelerate the global photoimmunotherapy market growth over the next five years.
Increased Cancer Prevalence Worldwide Drives the Market Growth
Cancer is a major health concern and is a leading cause of death across the globe. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020. During cancer, there is the rapid creation of abnormal cells that grow beyond their usual boundaries and can invade the adjoining parts of the body and spread to other organs, and the process is called metastasis. Some of the most common kinds of cancer are breast, lung, colon, rectum, and prostate cancers. In 2020, due to lung cancer, around 1.0 million deaths were observed. Similarly, for colon and rectum and liver cancer, the number of deaths in 2020 was 916000 and 830000. Adoption of an unhealthy and sedentary lifestyle, high body mass index, high alcohol, and tobacco consumption, and low fruit and vegetable intake are the main cancer-causing factors. Approximately 400 000 children develop cancer every year, and cervical cancer is the most common cancer in 23 countries. Cancer can be reduced through early detection and the right treatment and care of the patients. The majority of cancers can be cured if detected and treated early. Photoimmunotherapy is the recently developed hybrid cancer therapy that directly kills cancer cells as well as produces a therapeutic host immune response. Conventional immunotherapies such as checkpoint inhibition, engineered T cells and suppressor cell depletion, and immune-activating cytokine therapy do not directly destroy the cancer cells and rely on activating the immune system. Photoimmunotherapy selectively destroys the cancer cells, which releases cancer antigens from dying cancer cells. Therefore, the increased cancer incidence worldwide and the high mortality rate due to cancer are expected to bolster the global photoimmunotherapy market growth over the forecast period.
Favorable Government Policies Supports the Market Growth
The government of various countries are concerned with the growing number of cancer cases and are taking steps to lower the patient mortality rate due to cancer. They are providing financial support, reimbursing the cost incurred during the cancer treatment procedures, and funding cancer treatment research and development activities, among others. For instance, in India, some of the steps taken by the government that can fund cancer treatment are Health Minister's Cancer Patient Fund, The Health Minister's Discretionary Grants, The Central Government Health Scheme (CGHS), National Health Protection Scheme and The Prime Minister's National Relief Fund. Leading authorities of various countries are also promoting the adoption of novel technologies to treat cancer effectively. Massive support from the governments is making the market players invest and find new solutions for cancer treatment. Therefore, supportive government policies and the entry of new market players are expected to play a major role in boosting the global photoimmunotherapy market growth over the next five years.
Market Segmentation
The global photoimmunotherapy market is segmented into therapeutic area, end user, regional distribution, and competitive landscape. Based on therapeutic area, the market is divided into head & neck cancer, metastatic melanoma, and others. Based on end user, the market is divided into hospitals & clinics, ambulatory care centers, biotechnology & pharmaceutical companies, and others. The market analysis also studies the regional segmentation, which is divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to hold a significant market share due to the early adoption of advanced technologies by the healthcare sector and the presence of major market players in the country.
Market Players
Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., Luzitin SA are the major market players operating in the global photoimmunotherapy market.
Report Scope:
In this report, global photoimmunotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Photoimmunotherapy Market, By Therapeutic Area:
- Head & Neck Cancer
- Metastatic Melanoma
- Others
Photoimmunotherapy Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Biotechnology & Pharmaceutical Companies
- Others
Photoimmunotherapy Market, By Region:
- North America
- United States
- Mexico
- Canada
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global photoimmunotherapy market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Photoimmunotherapy Market
5. Voice of Customer
- 5.1. Therapy Awareness
- 5.2. Cancer Prevalence, By Gender
- 5.3. Cancer Prevalence, By Age Group
- 5.4. Cancer Prevalence, By Region
6. Clinical Trial Analysis
7. Patent Analysis
8. Global Photoimmunotherapy Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others)
- 8.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others)
- 8.2.3. By Company (2021)
- 8.2.4. By Region
- 8.3. Product Market Map
9. North America Photoimmunotherapy Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Therapeutic Area
- 9.2.2. By End User
- 9.2.3. By Country
- 9.3. North America: Country Analysis
- 9.3.1. United States Photoimmunotherapy Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Therapeutic Area
- 9.3.1.2.2. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Mexico Photoimmunotherapy Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Therapeutic Area
- 9.3.2.2.2. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Canada Photoimmunotherapy Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Therapeutic Area
- 9.3.3.2.2. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. United States Photoimmunotherapy Market Outlook
10. Europe Photoimmunotherapy Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Therapeutic Area
- 10.2.2. By End User
- 10.2.3. By Country
- 10.3. Europe: Country Analysis
- 10.3.1. France Photoimmunotherapy Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Therapeutic Area
- 10.3.1.2.2. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Germany Photoimmunotherapy Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Therapeutic Area
- 10.3.2.2.2. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. United Kingdom Photoimmunotherapy Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Therapeutic Area
- 10.3.3.2.2. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.4. Italy Photoimmunotherapy Market Outlook
- 10.3.4.1. Market Size & Forecast
- 10.3.4.1.1. By Value
- 10.3.4.2. Market Share & Forecast
- 10.3.4.2.1. By Therapeutic Area
- 10.3.4.2.2. By End User
- 10.3.4.1. Market Size & Forecast
- 10.3.5. Spain Photoimmunotherapy Market Outlook
- 10.3.5.1. Market Size & Forecast
- 10.3.5.1.1. By Value
- 10.3.5.2. Market Share & Forecast
- 10.3.5.2.1. By Therapeutic Area
- 10.3.5.2.2. By End User
- 10.3.5.1. Market Size & Forecast
- 10.3.1. France Photoimmunotherapy Market Outlook
11. Asia-Pacific Photoimmunotherapy Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Therapeutic Area
- 11.2.2. By End User
- 11.2.3. By Country
- 11.3. Asia-Pacific: Country Analysis
- 11.3.1. China Photoimmunotherapy Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Therapeutic Area
- 11.3.1.2.2. By End User
- 11.3.1.1. Market Size & Forecast
- 11.3.2. India Photoimmunotherapy Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Therapeutic Area
- 11.3.2.2.2. By End User
- 11.3.2.1. Market Size & Forecast
- 11.3.3. South Korea Photoimmunotherapy Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Therapeutic Area
- 11.3.3.2.2. By End User
- 11.3.3.1. Market Size & Forecast
- 11.3.4. Japan Photoimmunotherapy Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Therapeutic Area
- 11.3.4.2.2. By End User
- 11.3.4.1. Market Size & Forecast
- 11.3.5. Australia Photoimmunotherapy Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.1.1. By Value
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Therapeutic Area
- 11.3.5.2.2. By End User
- 11.3.5.1. Market Size & Forecast
- 11.3.1. China Photoimmunotherapy Market Outlook
12. South America Photoimmunotherapy Market Outlook
- 12.1. Market Size & Forecast
- 12.1.1. By Value
- 12.2. Market Share & Forecast
- 12.2.1. By Therapeutic Area
- 12.2.2. By End User
- 12.2.3. By Country
- 12.3. South America: Country Analysis
- 12.3.1. Brazil Photoimmunotherapy Market Outlook
- 12.3.1.1. Market Size & Forecast
- 12.3.1.1.1. By Value
- 12.3.1.2. Market Share & Forecast
- 12.3.1.2.1. By Therapeutic Area
- 12.3.1.2.2. By End User
- 12.3.1.1. Market Size & Forecast
- 12.3.2. Argentina Photoimmunotherapy Market Outlook
- 12.3.2.1. Market Size & Forecast
- 12.3.2.1.1. By Value
- 12.3.2.2. Market Share & Forecast
- 12.3.2.2.1. By Therapeutic Area
- 12.3.2.2.2. By End User
- 12.3.2.1. Market Size & Forecast
- 12.3.3. Colombia Photoimmunotherapy Market Outlook
- 12.3.3.1. Market Size & Forecast
- 12.3.3.1.1. By Value
- 12.3.3.2. Market Share & Forecast
- 12.3.3.2.1. By Therapeutic Area
- 12.3.3.2.2. By End User
- 12.3.3.1. Market Size & Forecast
- 12.3.1. Brazil Photoimmunotherapy Market Outlook
13. Middle East and Africa Photoimmunotherapy Market Outlook
- 13.1. Market Size & Forecast
- 13.1.1. By Value
- 13.2. Market Share & Forecast
- 13.2.1. By Therapeutic Area
- 13.2.2. By End User
- 13.2.3. By Country
- 13.3. MEA: Country Analysis
- 13.3.1. South Africa Photoimmunotherapy Market Outlook
- 13.3.1.1. Market Size & Forecast
- 13.3.1.1.1. By Value
- 13.3.1.2. Market Share & Forecast
- 13.3.1.2.1. By Therapeutic Area
- 13.3.1.2.2. By End User
- 13.3.1.1. Market Size & Forecast
- 13.3.2. Saudi Arabia Photoimmunotherapy Market Outlook
- 13.3.2.1. Market Size & Forecast
- 13.3.2.1.1. By Value
- 13.3.2.2. Market Share & Forecast
- 13.3.2.2.1. By Therapeutic Area
- 13.3.2.2.2. By End User
- 13.3.2.1. Market Size & Forecast
- 13.3.3. UAE Photoimmunotherapy Market Outlook
- 13.3.3.1. Market Size & Forecast
- 13.3.3.1.1. By Value
- 13.3.3.2. Market Share & Forecast
- 13.3.3.2.1. By Therapeutic Area
- 13.3.3.2.2. By End User
- 13.3.3.1. Market Size & Forecast
- 13.3.1. South Africa Photoimmunotherapy Market Outlook
14. Market Dynamics
- 14.1. Drivers
- 14.2. Challenges
15. Market Trends & Developments
16. Competitive Landscape
- 16.1. Rakuten Medical, Inc.
- 16.2. Shimadzu Corporation
- 16.3. Modulight Corporation
- 16.4. Steba Biotech Ltd.
- 16.5. Luzitin SA
17. Strategic Recommendations
